Fluoxymesterone
Inquiry
| Post Date: | Jan 23,2014 |
| Expiry Date: | Jan 23,2015 |
| Detailed Description: |
Cas No. :76-43-7
"Fluoxymesterone
Fluoxymesterone CAS NO.:76-43-7 Fluoxymesterone Molecular Formula:C20H29FO3 Fluoxymesterone Molecular Weight: 336.44 Fluoxymesterone Assay: 99% Fluoxymesterone Fluoxymesterone (Halotestin) is an anabolic steroid with strong androgenic properties that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. It is approximately 5 times as potent as methyltestosterone. The antitumor activity of fluoxymesterone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production. Fluoxymesterone Standard: Enterprise Standard Fluoxymesterone Packing: 1kg/aluminum foil bag Fluoxymesterone min. order quantity: 50g Fluoxymesterone Payment: Western Union, Moneygram, Paypal Fluoxymesterone Shipment: EMS, DHL, FeDex Fluoxymesterone Delivery: safe & timely, around 7days after payment." |
| CAS Registry Number: | 76-43-7 |
| Synonyms: | ;fluoxymesterone standard solution;fluoxymesterone--dea schedule iii;9-alpha-fluoro-11-beta,17-beta-dihydroxy-17-alpha-methylandrost-4-en-3-one;(11beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one; |
| Molecular Formula: | C20H29FO3 |
| Molecular Weight: | 336.4409 |
| Molecular Structure: | 
|
| Safety Description: | S24/25:; |
| Company: | Landmark Nutraceuimticals Co., Lited [ China ] |
| Contact: | cloudy |
| Tel: | 86-755-83721793 |
| Fax: | 86-755-83721793 |
| Email: | landmarksale10@gmail.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
